PTC THERAPEUTICS, INC. 8-K

What Happened

• On February 19, 2026, PTC Therapeutics, Inc. announced its financial results for the quarter and fiscal year ended December 31, 2025 by issuing a press release (furnished as Exhibit 99.1 to the Form 8‑K). The company also scheduled a conference call for February 19, 2026 at 4:30 p.m. Eastern Time to review the results, corporate highlights and updates.

Key Details

• Filing date: February 19, 2026; reporting period: quarter and fiscal year ended December 31, 2025.
• Press release with financial results is furnished as Exhibit 99.1 to the Form 8‑K.
• Conference call: February 19, 2026 at 4:30 p.m. ET; access instructions are included in the press release.
• The Form 8‑K states the furnished information (including the press release and call details) is not “filed” for purposes of Section 18 of the Exchange Act. The report was signed by CFO Pierre Gravier.

Why It Matters

• This filing is how PTC formally announced its latest earnings and set the time for management to discuss quarterly and full‑year results — key moments for investors to hear revenue, profitability, guidance changes, or program updates directly from management.
• Retail investors should review the Exhibit 99.1 press release and consider listening to the Feb 19 earnings call for the detailed financial metrics and management commentary that could affect near‑term stock performance and investment decisions.